April 24, 2026 · Form 4 insider transaction
Fried Robert N bought 20,000 shares of Niagen Bioscience, Inc. at $2.61 per share, a transaction worth $52.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
The Reporting Person exercised the stock options reported on this Form 4 in advance of their expiration on November 15, 2026, paying the exercise price with cash, and has not sold any of the shares received upon exercise.